FDA Certifies Novel ADHD Drug

by Savitha C Muppala on  February 26, 2007 at 8:04 PM Drug News   - G J E 4
FDA Certifies Novel ADHD Drug
Washington - The FDA has permitted the use of a new drug to treat attention deficit hyperactivity disorder. The drug known as Vyvanse, is manufactured by Shire PLC.

The company hopes that patients can have a smooth transition from the older ADHD medications to Vyvanse.

The company has further confirmed that the present drug is promising because it is difficult to abuse. The effect of this drug is best realized only when it is swallowed.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like